{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:57:11Z","timestamp":1774263431723,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ad.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T08:01:39Z","timestamp":1457769699000},"page":"454-464","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Neurofibromatosis tipo 1: m\u00e1s que manchas caf\u00e9 con leche, ef\u00e9lides y neurofibromas. Parte I. Actualizaci\u00f3n sobre los criterios dermatol\u00f3gicos diagn\u00f3sticos de la enfermedad"],"prefix":"10.1016","volume":"107","author":[{"given":"A.","family":"Hern\u00e1ndez-Mart\u00edn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Duat-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2016.01.004_bib0295","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/adc.64.5.745","article-title":"Recent developments in the diagnosis and management of neurofibromatosis","volume":"64","author":"Huson","year":"1989","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ad.2016.01.004_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","article-title":"Epidemiology of neurofibromatosis type 1","volume":"89","author":"Friedman","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ad.2016.01.004_bib0305","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1126\/science.3107130","article-title":"Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17","volume":"236","author":"Barker","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.ad.2016.01.004_bib0310","first-page":"575","article-title":"Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.ad.2016.01.004_bib0315","first-page":"M73","article-title":"Mouse models of neurofibromatosis","volume":"1471","author":"McClatchey","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ad.2016.01.004_bib0320","first-page":"402","article-title":"[Rasopathies: Developmental disorders that predispose to cancer and skin manifestations]","volume":"102","author":"Hernandez-Martin","year":"2011","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2016.01.004_bib0325","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.56.11.1433","article-title":"The clinical and diagnostic implications of mosaicism in the neurofibromatoses","volume":"56","author":"Ruggieri","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.ad.2016.01.004_bib0330","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/1096-8628(20010201)98:4<363::AID-AJMG1101>3.0.CO;2-A","article-title":"Large plexiform neurofibromas may be explained as a type 2 segmental manifestation of neurofibromatosis 1","volume":"98","author":"Happle","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ad.2016.01.004_bib0335","first-page":"173","article-title":"Phenotypic and genetic features in neurofibromatosis type 1 in children","volume":"83","author":"Duat Rodriguez","year":"2015","journal-title":"An Pediatr (Barc)"},{"key":"10.1016\/j.ad.2016.01.004_bib0340","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1017\/S0317167100004017","article-title":"Neurofibromatosis type 1 in a pediatric population: Ste-Justine's experience","volume":"32","author":"Boulanger","year":"2005","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.ad.2016.01.004_bib0345","series-title":"Caracter\u00edsticas fenot\u00edpicas y gen\u00e9ticas en la neurofibromatosis tipo 1 en la edad pedi\u00e1trica [tesis doctoral]. Facultad de Medicina. Departamento de Pediatr\u00eda","author":"Duat Rodriguez","year":"2015"},{"key":"10.1016\/j.ad.2016.01.004_bib0350","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.pcl.2010.07.002","article-title":"The diagnostic and clinical significance of cafe-au-lait macules","volume":"57","author":"Shah","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.ad.2016.01.004_bib0355","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000327379","article-title":"Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: A cross-sectional study of 728 patients","volume":"222","author":"Duong","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.ad.2016.01.004_bib0360","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archdermatol.2009.169","article-title":"Predictive value of cafe au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1","volume":"145","author":"Nunley","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2016.01.004_bib0365","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1542\/peds.105.3.608","article-title":"Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children","volume":"105","author":"DeBella","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/j.ad.2016.01.004_bib0370","first-page":"313","article-title":"[Diagnostic value of cafe-au-lait spots (author's transl)]","volume":"107","author":"Ortonne","year":"1980","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ad.2016.01.004_bib0375","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00403-006-0644-6","article-title":"Cafe-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: Hyperpigmentation of a different kind?","volume":"297","author":"De Schepper","year":"2006","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.ad.2016.01.004_bib0380","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/BF00204170","article-title":"Increased melanogenesis in cultured epidermal melanocytes from patients with neurofibromatosis 1 (NF 1)","volume":"87","author":"Kaufmann","year":"1991","journal-title":"Hum Genet"},{"key":"10.1016\/j.ad.2016.01.004_bib0385","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/519562","article-title":"Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1","volume":"81","author":"Maertens","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ad.2016.01.004_bib0390","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/adc.41.217.316","article-title":"Diagnostic value of the cafe-au-lait spot in children","volume":"41","author":"Whitehouse","year":"1966","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ad.2016.01.004_bib0395","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/adc.57.8.631","article-title":"Cafe-au-lait spots in schoolchildren","volume":"57","author":"Burwell","year":"1982","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.ad.2016.01.004_bib0400","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ng2113","article-title":"Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype","volume":"39","author":"Brems","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.ad.2016.01.004_bib0405","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2302\/kjm.2013-0002-RE","article-title":"Legius syndrome, an Update. Molecular pathology of mutations in SPRED1","volume":"62","author":"Brems","year":"2013","journal-title":"Keio J Med"},{"key":"10.1016\/j.ad.2016.01.004_bib0410","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1001\/jama.2009.1663","article-title":"Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome","volume":"302","author":"Messiaen","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ad.2016.01.004_bib0415","doi-asserted-by":"crossref","DOI":"10.1002\/humu.22832","article-title":"High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.Arg1809: Genotype-phenotype correlation","author":"Rojnueangnit","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.ad.2016.01.004_bib0420","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1086\/498454","article-title":"NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome","volume":"77","author":"De Luca","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ad.2016.01.004_bib0425","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.ad.2014.11.004","article-title":"LEOPARD syndrome without hearing loss or pulmonary stenosis: A report of 2 cases","volume":"106","author":"Ramos-Geldres","year":"2015","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.ad.2016.01.004_bib0430","doi-asserted-by":"crossref","DOI":"10.2340\/00015555-2123","article-title":"Pathogenesis of multiple lentigines in LEOPARD syndrome with PTPN11 gene mutation","author":"Motegi","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ad.2016.01.004_bib0435","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1111\/j.1525-1470.2008.00734.x","article-title":"LEOPARD syndrome: What are cafe noir spots?","volume":"25","author":"Rodriguez-Bujaldon","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ad.2016.01.004_bib0440","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1111\/pde.12494","article-title":"Clinicopathologic evaluation of cardiofaciocutaneous syndrome: Overcoming the challenges of diagnosing a rare genodermatosis","volume":"32","author":"Bryan","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ad.2016.01.004_bib0445","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/pde.12171","article-title":"Cutaneous manifestations in Costello and cardiofaciocutaneous syndrome: Report of 18 cases and literature review","volume":"30","author":"Morice-Picard","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ad.2016.01.004_bib0450","first-page":"521","article-title":"Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome","volume":"164","author":"Siegel","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ad.2016.01.004_bib0455","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3324\/haematol.2014.114595","article-title":"RAS diseases in children","volume":"99","author":"Niemeyer","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.ad.2016.01.004_bib0460","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ajmg.a.36288","article-title":"Multiple cafe au lait spots in familial patients with MAP2K2 mutation","volume":"164A","author":"Takenouchi","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ad.2016.01.004_bib0465","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1750-1172-4-16","article-title":"Neurofibromatosis type 2 (NF2): A clinical and molecular review","volume":"4","author":"Evans","year":"2009","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ad.2016.01.004_bib0470","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/ajmg.a.35297","article-title":"Cafe-au-lait macules and intertriginous freckling in piebaldism: Clinical overlap with neurofibromatosis type 1 and Legius syndrome","volume":"158A","author":"Stevens","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ad.2016.01.004_bib0475","first-page":"635","article-title":"A novel missense KIT mutation causing piebaldism in one Chinese family associated with cafe-au-lait macules and intertriginous freckling","volume":"11","author":"Jia","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ad.2016.01.004_bib0480","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1525-1470.2012.01858.x","article-title":"Association of piebaldism, multiple cafe-au-lait macules, and intertriginous freckling: Clinical evidence of a common pathway between KIT and sprouty-related, ena\/vasodilator-stimulated phosphoprotein homology-1 domain containing protein 1 (SPRED1)","volume":"30","author":"Chiu","year":"2013","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ad.2016.01.004_bib0485","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.ejca.2015.02.008","article-title":"Phenotypic and genotypic characterisation of biallelic mismatch repair deficiency (BMMR-D) syndrome","volume":"51","author":"Durno","year":"2015","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ad.2016.01.004_bib0490","first-page":"717","article-title":"The diagnosis of neurofibromatosis-1 in the child under the age of 6 years","volume":"143","author":"Obringer","year":"1989","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.ad.2016.01.004_bib0495","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.ejim.2014.04.004","article-title":"Is it time to change the neurofibromatosis 1 diagnostic criteria?","volume":"25","author":"Tadini","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ad.2016.01.004_bib0500","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1093\/hmg\/9.20.3055","article-title":"Schwann cells harbor the somatic NF1 mutation in neurofibromas: Evidence of two different Schwann cell subpopulations","volume":"9","author":"Serra","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ad.2016.01.004_bib0505","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1474-4422(14)70063-8","article-title":"Neurofibromatosis type 1: A multidisciplinary approach to care","volume":"13","author":"Hirbe","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ad.2016.01.004_bib0510","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2008.061051","article-title":"Longitudinal study of neurofibromatosis 1 associated plexiform neurofibromas","volume":"46","author":"Tucker","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.ad.2016.01.004_bib0515","first-page":"223","article-title":"Neurofibromatosis type 1","volume":"222","author":"McLaughlin","year":"2003","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.ad.2016.01.004_bib0520","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archderm.1982.01650200045014","article-title":"Blue-red macules and pseudoatrophic macules: Additional cutaneous signs in neurofibromatosis","volume":"118","author":"Westerhof","year":"1982","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.ad.2016.01.004_bib0525","first-page":"180","article-title":"[Blue-red macules and pseudoatrophic macules in neurofibromatosis 1]","volume":"129","author":"Zeller","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.ad.2016.01.004_bib0530","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5070\/D329S5592H","article-title":"Neurofibromatosis-Noonan syndrome: Case report and clinicopathogenic review of the neurofibromatosis-Noonan syndrome and RAS-MAPK pathway","volume":"17","author":"Reig","year":"2011","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.ad.2016.01.004_bib0535","first-page":"100","article-title":"Pseudoatrophic macules: A variant of neurofibroma","volume":"57","author":"Pique","year":"1996","journal-title":"Cutis"},{"key":"10.1016\/j.ad.2016.01.004_bib0540","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/pde.12310","article-title":"Ultrasound as a diagnostic aid in identifying neurofibromas","volume":"31","author":"Zarchi","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.ad.2016.01.004_bib0545","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1259\/dmfr\/81000210","article-title":"Imaging findings of neurogenic tumours in the head and neck region","volume":"41","author":"Kami","year":"2012","journal-title":"Dentomaxillofac Radiol"},{"key":"10.1016\/j.ad.2016.01.004_bib0550","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jpeds.2013.10.081","article-title":"Puberty and plexiform neurofibroma tumor growth in patients with neurofibromatosis type I","volume":"164","author":"Dagalakis","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/j.ad.2016.01.004_bib0555","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1038\/jid.2010.100","article-title":"NF-1Score: A prediction score for internal neurofibromas in neurofibromatosis-1","volume":"130","author":"Sbidian","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.ad.2016.01.004_bib0560","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.a.36793","article-title":"Recent developments in neurofibromatoses and RASopathies: Management, diagnosis and current and future therapeutic avenues","volume":"167A","author":"Rauen","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ad.2016.01.004_bib0565","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cge.12498","article-title":"The natural history of spinal neurofibromatosis: A critical review of clinical and genetic features","volume":"87","author":"Ruggieri","year":"2015","journal-title":"Clin Genet"},{"key":"10.1016\/j.ad.2016.01.004_bib0570","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/01676830600987227","article-title":"Orbitotemporal neurofibromatosis: Classification and treatment","volume":"26","author":"Erb","year":"2007","journal-title":"Orbit"},{"key":"10.1016\/j.ad.2016.01.004_bib0575","unstructured":"Neurofibroma. En: MCKee PH CE, Granter SR, editores. Pathology of the skin with clinical correlations. 3th ed. London: Elsevier Mosby; 2005. p. 1773-1774."},{"key":"10.1016\/j.ad.2016.01.004_bib0580","unstructured":"Neurofibromatosis Consortium 2015 [consultado 3 Nov 2015]. Disponible en: https:\/\/www.uab.edu\/nfconsortium\/"}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731016000636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731016000636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:04:38Z","timestamp":1757552678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731016000636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0001731016000636"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2016.01.004","relation":{},"ISSN":["0001-7310"],"issn-type":[{"value":"0001-7310","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofibromatosis tipo 1: m\u00e1s que manchas caf\u00e9 con leche, ef\u00e9lides y neurofibromas. Parte I. Actualizaci\u00f3n sobre los criterios dermatol\u00f3gicos diagn\u00f3sticos de la enfermedad","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 AEDV. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}